Related Experiment Video
Updated: Nov 11, 2025
06:22
Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
Published on: November 29, 2024
1.0K
Exploring the recent molecular targets for diabetes and associated complications
Amit Gupta1, Tapan Behl2, Aayush Sehgal1
1Chitkara College of Pharmacy, Chitkara University, Rajpura, Punjab, India.
Molecular Biology Reports
|March 25, 2021
Summary
Novel molecular targets show promise for managing diabetes and its complications, potentially offering superior benefits over conventional treatments. This research highlights new pathways for future clinical trials to improve patient outcomes.
Area of Science:
- Endocrinology and Metabolism
- Molecular Biology
- Pharmacology
Background:
- Diabetes mellitus is a major global health concern with escalating costs.
- Conventional diabetes treatments have limitations and side effects.
- There is a critical need for novel therapeutic strategies.
Purpose of the Study:
- To review recent molecular targets and pathways for diabetes management.
- To identify novel therapeutic approaches for diabetes and its complications.
- To evaluate the potential of new targets in preclinical and clinical settings.
Main Methods:
- Comprehensive literature review using MEDLINE, BIOSIS, and EMBASE databases.
- Keyword-based retrieval of relevant research and review papers.
- Analysis of in-vitro and in-vivo studies on molecular targets.
Main Results:
- Several molecular pathways and novel targets demonstrated significant promise.
- These targets showed efficacy in ameliorating diabetes in preclinical studies.
- Identified targets also aided in mitigating diabetes-associated complications.
Conclusions:
- Novel molecular targets offer a promising pipeline for diabetes therapy.
- These targets may provide benefits exceeding conventional treatments.
- Further clinical trials are warranted to validate these findings for improved diabetes care.
Keywords:
Diabetes managementDiabetic complicationDrug developmentNew targetsNovel mechanismType-2 diabetesMore Related Videos
Related Concept Videos
01:20Pathophysiology of Diabetes
2.3K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.3K
01:15Diabetes: Symptoms, Diagnosis, and Complications
1.4K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.4K
01:22Diabetes Mellitus: Type 2 and Gestational
3.7K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.7K
01:22Diabetes Mellitus: Overview and Type I Subtype
4.2K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.2K
01:15Diabetes: Management and Pharmacotherapy
688
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
688
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
426
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
426